Cargando…

SWEDEGENE—a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions

SWEDEGENE is a Swedish nation-wide sample collection established to facilitate studies of clinical and genetic risk factors for adverse drug reactions (ADRs). Most cases are recruited among patients reported to the ADR registry at the Swedish Medical Products Agency by health-care professionals. Cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hallberg, Pär, Yue, Qun-Ying, Eliasson, Erik, Melhus, Håkan, Ås, Joel, Wadelius, Mia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375949/ https://www.ncbi.nlm.nih.gov/pubmed/31949290 http://dx.doi.org/10.1038/s41397-020-0148-3

Ejemplares similares

Identification of risk factors for carbamazepine-induced serious mucocutaneous adverse reactions: A case-control study using data from spontaneous adverse drug reaction reports
por: Bertulyte, Ilma, et al.
Publicado: (2014)

Clinical factors predicting drug-induced liver injury due to flucloxacillin
por: Lindh, Mikaela, et al.
Publicado: (2018)

Fusidic Acid: A Neglected Risk Factor for Statin-Associated Myopathy
por: Rönnqvist, Josefine, et al.
Publicado: (2018)

Can mutations in ELA2, neutrophil elastase expression or differential cell toxicity explain sulphasalazine-induced agranulocytosis?
por: Jacobson, Annica, et al.
Publicado: (2004)

Pharmacogenomics and personalized medicine: the plunge into next-generation sequencing
por: Wadelius, Mia, et al.
Publicado: (2011)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

HLA variants associated with azathioprine‐induced pancreatitis in patients with Crohn’s disease
por: Ås, Joel, et al.
Publicado: (2022)

A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017)

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
por: Cacabelos, Ramón, et al.
Publicado: (2021)

Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
por: Englund, Gunilla, et al.
Publicado: (2004)

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long‐term follow‐up of predictors, surveillance, and outcome in clinical practice
por: Karlsson Sundbaum, Johanna, et al.
Publicado: (2019)

Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions
por: Tong, Hang, et al.
Publicado: (2021)

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam
por: Campbell, Ciarán, et al.
Publicado: (2022)

The Apportionment of Pharmacogenomic Variation: Race, Ethnicity, and Adverse Drug Reactions
por: Jordan, I. King, et al.
Publicado: (2022)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival
por: Hallberg, Pär, et al.
Publicado: (2019)

Predicting serious rare adverse reactions of novel chemicals
por: Poleksic, Aleksandar, et al.
Publicado: (2018)

Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
por: Dao, Ro-Lan, et al.
Publicado: (2015)

Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation
por: King, Charlotte, et al.
Publicado: (2020)

A Case of Serious Adverse Reaction Following Rabies Vaccination
por: Kang, Zhilin, et al.
Publicado: (2018)

Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization
por: King, Charlotte, et al.
Publicado: (2020)

Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
por: Thomsen, Henrik S.
Publicado: (2006)

The Necessity of a Nationwide Surveillance System of Serious BCG Adverse Reactions
por: Cho, Hye-Kyung
Publicado: (2019)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Serious adverse drug reactions at two children’s hospitals in South Africa
por: Mouton, Johannes P., et al.
Publicado: (2020)

Healthcare costs and mortality associated with serious fluoroquinolone‐related adverse reactions
por: Kuula, Laura S.M., et al.
Publicado: (2022)

The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods
por: Stocchi, Laura, et al.
Publicado: (2012)

Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016)

An analysis of serious adverse drug reactions at a tertiary care teaching hospital
por: Prajapati, Kinjal, et al.
Publicado: (2016)

Risk Factors for Doxorubicin-Induced Serious Hyperglycaemia-Related Adverse Drug Reactions
por: Yang, Jincheng, et al.
Publicado: (2019)

Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations
por: Cismaru, Anca Liliana, et al.
Publicado: (2020)

The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
por: Yue, Qun-Ying
Publicado: (2021)

Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
por: Alessandrini, Marco, et al.
Publicado: (2016)

Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study
por: Just, Katja S., et al.
Publicado: (2020)

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions
por: Calderon-Ospina, Carlos Alberto, et al.
Publicado: (2020)

Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole
por: Franco, Lucas A. M., et al.
Publicado: (2021)

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
por: Kloypan, Chiraphat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hmvct5iph3vjibqvitourr6dvb